Leaflet NPLATE 500mcg powder for solution for injection

Product code:
W53895001
Quantity:
1
Indicated for:
thrombocytopenia
Route of administration:
injectable
Substance:
romiplostim (fusion protein)
ATC
B02BX04 — Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics
Romiplostim is a thrombopoietin receptor agonist used in the treatment of primary immune thrombocytopenia (ITP) in patients who do not respond to other therapies such as corticosteroids or immunoglobulins. It stimulates platelet production by activating thrombopoietin receptors on megakaryocyte progenitor cells in the bone marrow.

Romiplostim is administered as a subcutaneous injection, usually once weekly, with the dose adjusted based on the patient's platelet levels. It is used to reduce the risk of bleeding and improve the quality of life for patients with chronic ITP.

Common side effects include headache, fatigue, nausea, and muscle pain. In rare cases, severe adverse reactions such as thrombosis or bone marrow fibrosis may occur. Regular monitoring of blood counts and overall health is essential during treatment.

Romiplostim is an effective therapeutic option for patients with ITP, helping to increase platelet counts and reduce the risk of bleeding complications.

General data about NPLATE 500mcg

Substance:
romiplostim
Date of latest medicines list:
01-04-2017
Product code:
W53895001
Concentration:
500mcg
Pharmaceutical form:
powder for solution for injection
Quantity:
1
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Concentrations available for romiplostim

  • 250mcg
  • 500mcg